Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Urodynamic Studies: Uroflowmetry01:19

Urodynamic Studies: Uroflowmetry

590
Uroflowmetry is a non-invasive urodynamic test designed to measure various aspects of urination, including volume, flow rate, and the time to void. This test is crucial for diagnosing and assessing conditions such as bladder outlet obstruction, bladder dysfunction, incomplete bladder emptying, incontinence, and urinary tract blockages caused by benign prostatic hyperplasia (BPH) and urethral strictures.Pre-Test Instructions:Before a uroflowmetry test, patients are typically advised to drink...
590
Imaging Studies VI: Voiding Cystourethrography and Cystography01:22

Imaging Studies VI: Voiding Cystourethrography and Cystography

120
Voiding Cystourethrography (VCUG) and Cystography are specialized radiographic procedures used to examine the structure and function of the bladder and urethra.Voiding Cystourethrography (VCUG)A Voiding Cystourethrogram (VCUG) is a diagnostic imaging procedure that assesses the anatomy and function of the lower urinary tract. It focuses on the bladder, bladder neck, and urethra, helping detect abnormalities such as vesicoureteral reflux (VUR)—the backward or reverse flow of urine into the...
120
Rapidly Varying Flow01:24

Rapidly Varying Flow

140
Rapidly varying flow (RVF) in open channels is characterized by abrupt changes in flow depth over a short distance, with the rate of depth change relative to distance often approaching unity. These flows are inherently complex due to their transient and multi-dimensional nature, making exact analysis difficult. However, approximate solutions using simplified models provide valuable insights into their behavior.Key Features of Rapidly Varying FlowRVF is commonly observed in scenarios involving...
140
Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa01:22

Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa

277
The pH of urine, the drug's pKa, and the urine flow rate are vital parameters for drug reabsorption and excretion. Urinary pH varies between 4.6 and 8.0 and is influenced by diet, drug intake, and the patient's pathophysiology. It affects a drug's ionization state and reabsorption. For instance, carbohydrate-rich food produces alkaline urine promoting drug excretion, while proteins and certain medications like ascorbic acid lead to acidic urine enhancing reabsorption.
The pKa of a...
277

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Younger age at colorectal cancer diagnosis in hereditary gastrointestinal cancer predisposition syndromes and Lynch syndrome: a nationwide analysis.

Journal of gastrointestinal oncology·2026
Same author

Sodium Alginate-Based Submucosal Lifting Hydrogel for Endoscopic Mucosal Resection and Endoscopic Submucosal Dissection.

Advanced healthcare materials·2026
Same author

Ethnicity, trial era, and timing: reappraising heterogeneity in the clopidogrel vs aspirin meta-analysis for chronic coronary syndromes.

European heart journal·2026
Same author

Risk of Myeloproliferative Neoplasms in Patients With Inflammatory Bowel Disease and Impact on Outcomes: A Multi-Centre Matched Analysis.

Alimentary pharmacology & therapeutics·2026
Same author

Irreversible electroporation in focal therapy for prostate cancer: current status and future directions.

Prostate international·2026
Same author

Cost-Utility Analysis of High-Intensity Statins; Atorvastatin 40 and 80 mg versus Rosuvastatin 20 mg from Egyptian Public Payer's Perspective: A Markov Model.

International journal of preventive medicine·2026

相关实验视频

Updated: Sep 13, 2025

Author Spotlight: Advanced Treatment of Seminal Duct Blockage Employing Endoscopy-Mediated Semen Channel Refluviation
03:51

Author Spotlight: Advanced Treatment of Seminal Duct Blockage Employing Endoscopy-Mediated Semen Channel Refluviation

Published on: December 8, 2023

3.2K

使用最大流速 (Q-max) 作为客观结果,预测小穴后的早期空气排放模式.

Abdulmalik Addar1, Adel Arezki2, Tarek Benzouak3,4

  • 1Division of Urology, McGill University, Montreal, Canada. abdulmalik.addar@mail.mcgill.ca.

World journal of urology
|July 30, 2025
PubMed
概括

晚年,糖尿病和组合BPH治疗预测前列腺的霍尔激光除核术 (HoLEP) 后尿液流量较差. 识别这些因素有助于量身定制的患者管理,以获得更好的结果.

关键词:
良性前列腺增生症是什么荷尔激光去核前列腺激光切除术最大的尿流率是什么?手术前的预测因素泌尿器科 泌尿器科 泌尿器科 泌尿器科排空功能障碍是什么意思

更多相关视频

Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate HoLEP.
06:04

Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate HoLEP.

Published on: March 6, 2018

17.1K
Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing
05:25

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing

Published on: August 14, 2019

19.3K

相关实验视频

Last Updated: Sep 13, 2025

Author Spotlight: Advanced Treatment of Seminal Duct Blockage Employing Endoscopy-Mediated Semen Channel Refluviation
03:51

Author Spotlight: Advanced Treatment of Seminal Duct Blockage Employing Endoscopy-Mediated Semen Channel Refluviation

Published on: December 8, 2023

3.2K
Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate HoLEP.
06:04

Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate HoLEP.

Published on: March 6, 2018

17.1K
Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing
05:25

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing

Published on: August 14, 2019

19.3K

科学领域:

  • 泌尿器科 泌尿器科 泌尿器科 泌尿器科
  • 手术创新 在外科创新.
  • 患者的治疗结果.

背景情况:

  • 前列腺的霍尔激光核化 (HoLEP) 是良性前列腺增生症 (BPH) 的领先治疗方法.
  • 尽管HoLEP的疗效,一些患者经历了持续的下最佳空白术后.
  • 预测这些结果对于优化患者选择和管理至关重要.

研究的目的:

  • 为了确定 HoLEP 后缺陷排泄模式的术前预测因素.
  • 用最大尿流速 (Q-max) 客观地测量排泄结果.

主要方法:

  • 对1121名接受HoLEP治疗的患者进行了回顾性分析.
  • 数据包括人口统计,手术前参数和手术细节.
  • 糟糕的排空被定义为Q-max<15毫升/秒在一个月;用于分析的逻辑回归.

主要成果:

  • 晚年,糖尿病和手术前组合BPH治疗独立地与 postoperative Q-max 相关.
  • 核化组织重量增加对Q-max有保护作用.
  • 多变量分析证实了这些预测因素具有统计学意义.

结论:

  • 术前因素,如晚年,糖尿病和联合BPH疗法预测HoLEP后的低最佳空气排放.
  • 这些发现强调了个性化手术前评估的重要性.
  • 量身定制的管理策略对于改善HoLEP后患者的治疗结果至关重要.